Replies to post #239730 on Biotech Values

[DewDiligence]

FOLD cancels gene-therapy spinoff with SPAC:

https://finance.yahoo.com/news/arya-sciences-acquisition-corp-iv-120000404.html

The decision is based on adverse market conditions, according to the companies.